{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:21:50Z","timestamp":1783146110463,"version":"3.54.6"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004955","name":"\u00d6sterreichische Forschungsf\u00f6rderungsgesellschaft mbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002243","name":"National Ataxia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003390","name":"Fritz Thyssen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001660","name":"Schering Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.xcrm.2026.102822","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:35:47Z","timestamp":1779114947000},"page":"102822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synaptophysin autoantibodies mediate synaptic dysfunction in cerebellar ataxia"],"prefix":"10.1016","volume":"7","author":[{"given":"Samantha","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi Kiu","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorina","family":"Shqau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Winklmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Grobe-Einsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Rostasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"K\u00fcmpfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska S.","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Brimberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Muley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atay","family":"Vural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Seifert-Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Endmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"H\u00f6ftberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klopstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Frahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Ann","family":"Gerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Meinl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2844-9091","authenticated-orcid":false,"given":"Simone","family":"Mader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102822_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12311-021-01359-z","article-title":"Advances in the Pathogenesis of Auto-antibody-Induced Cerebellar Synaptopathies","volume":"22","author":"Mitoma","year":"2023","journal-title":"Cerebellum"},{"key":"10.1016\/j.xcrm.2026.102822_bib2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/WCO.0000000000001260","article-title":"Neuronal antibodies in nonparaneoplastic autoimmune cerebellar ataxias","volume":"37","author":"Saiz","year":"2024","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.xcrm.2026.102822_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/B978-0-12-823912-4.00004-9","article-title":"Paraneoplastic movement disorders","volume":"200","author":"McKeon","year":"2024","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.xcrm.2026.102822_bib4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.it.2015.09.008","article-title":"Antibodies as Mediators of Brain Pathology","volume":"36","author":"Brimberg","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.xcrm.2026.102822_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/brain\/awx189","article-title":"Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology","volume":"141","author":"Balint","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2026.102822_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1474-4422(23)00083-2","article-title":"Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease","volume":"22","author":"Dalmau","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.xcrm.2026.102822_bib7","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41577-021-00543-w","article-title":"Autoantibodies in neurological disease","volume":"21","author":"Pr\u00fcss","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102822_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ana.25120","article-title":"Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia","volume":"83","author":"Patterson","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xcrm.2026.102822_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.xcrm.2026.102822_bib10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jamaneurol.2016.1585","article-title":"Characterization of a Subtype of Autoimmune Encephalitis With Anti-Contactin-Associated Protein-like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures","volume":"73","author":"Joubert","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.xcrm.2026.102822_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.xcrm.2026.102822_bib12","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000207","article-title":"Immunoadsorption therapy in autoimmune encephalitides","volume":"3","author":"Dogan Onugoren","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.xcrm.2026.102822_bib13","article-title":"Anti-LGI1 Autoimmune Limbic Encephalitis: An Easy-To-Miss Diagnosis","volume":"11","author":"Freitas Henriques","year":"2024","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"10.1016\/j.xcrm.2026.102822_bib14","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200360","article-title":"Cognitive Deficits in Anti-LGI1 Encephalitis Are Linked to Immunotherapy-Resistant White Matter Network Changes","volume":"12","author":"Krohn","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.xcrm.2026.102822_bib15","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.3389\/fimmu.2018.02568","article-title":"Encephalitis Associated to Metabotropic Glutamate Receptor 5 (mGluR5) Antibodies in Cerebrospinal Fluid","volume":"9","author":"Guevara","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102822_bib16","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/jnnp.2003.014662","article-title":"Population based study of late onset cerebellar ataxia in south east Wales","volume":"75","author":"Muzaimi","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.xcrm.2026.102822_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejpn.2023.10.005","article-title":"Autoantibody status, neuroradiological and clinical findings in children with acute cerebellitis","volume":"47","author":"Quack","year":"2023","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.xcrm.2026.102822_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.str.2007.04.011","article-title":"Structure of synaptophysin: a hexameric MARVEL-domain channel protein","volume":"15","author":"Arthur","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.xcrm.2026.102822_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/alz.12409","article-title":"Slowly progressive behavioral frontotemporal dementia syndrome in a family co-segregating the C9orf72 expansion and a Synaptophysin mutation","volume":"18","author":"Prota","year":"2022","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.xcrm.2026.102822_bib20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.nbd.2017.08.021","article-title":"Altered synaptobrevin-II trafficking in neurons expressing a synaptophysin mutation associated with a severe neurodevelopmental disorder","volume":"108","author":"Harper","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.xcrm.2026.102822_bib21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.367","article-title":"A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation","volume":"41","author":"Tarpey","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2026.102822_bib22","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1212\/WNL.0000000000004311","article-title":"Clinical and genetic characteristics of sporadic adult-onset degenerative ataxia","volume":"89","author":"Giordano","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.xcrm.2026.102822_bib23","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/mds.29324","article-title":"Evolution of Clinical Outcome Measures and Biomarkers in Sporadic Adult-Onset Degenerative Ataxia","volume":"38","author":"Oender","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.xcrm.2026.102822_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105715","article-title":"The genetic landscape of sporadic adult-onset degenerative ataxia: a multi-modal genetic study of 377 consecutive patients from the longitudinal multi-centre SPORTAX cohort","volume":"115","author":"Beijer","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2026.102822_bib25","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/clinchem\/37.7.1153","article-title":"Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain","volume":"37","author":"Reiber","year":"1991","journal-title":"Clin. Chem."},{"key":"10.1016\/j.xcrm.2026.102822_bib26","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ana.20890","article-title":"B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation","volume":"59","author":"Meinl","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xcrm.2026.102822_bib27","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification","volume":"10","author":"Travis","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.xcrm.2026.102822_bib28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.stemcr.2017.02.016","article-title":"Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes","volume":"8","author":"Pawlowski","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102822_bib29","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.neuron.2011.04.001","article-title":"Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons","volume":"70","author":"Kwon","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.xcrm.2026.102822_bib30","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s12311-022-01468-3","article-title":"Clinical Features and Neuroimaging Findings of Neuropil Antibody-Positive Idiopathic Sporadic Ataxia of Unknown Etiology","volume":"22","author":"Takekoshi","year":"2023","journal-title":"Cerebellum"},{"key":"10.1016\/j.xcrm.2026.102822_bib31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41582-024-01012-3","article-title":"Stiff-person syndrome and related disorders - diagnosis, mechanisms and therapies","volume":"20","author":"Dalakas","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.xcrm.2026.102822_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archneur.58.2.225","article-title":"Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients","volume":"58","author":"Honnorat","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.xcrm.2026.102822_bib33","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamaneurol.2014.1011","article-title":"Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy","volume":"71","author":"Ari\u00f1o","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.xcrm.2026.102822_bib34","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000474","article-title":"Autoimmune septin-5 cerebellar ataxia","volume":"5","author":"Honorat","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.xcrm.2026.102822_bib35","article-title":"Anti-amphiphysin encephalitis: Expanding the clinical spectrum","volume":"14","author":"Sun","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102822_bib36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s12311-020-01132-8","article-title":"Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia-Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias","volume":"19","author":"Hadjivassiliou","year":"2020","journal-title":"Cerebellum"},{"key":"10.1016\/j.xcrm.2026.102822_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneuroim.2008.03.018","article-title":"Synaptophysin is an autoantigen in paraneoplastic neuropathy","volume":"197","author":"Tschernatsch","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.xcrm.2026.102822_bib38","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.0000000000002476","article-title":"Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes","volume":"86","author":"Lopez-Chiriboga","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.xcrm.2026.102822_bib39","doi-asserted-by":"crossref","first-page":"e3012","DOI":"10.1212\/WNL.0000000000010854","article-title":"Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis","volume":"95","author":"Spatola","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.xcrm.2026.102822_bib40","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.xcrm.2026.102822_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/1570159X16666180917105033","article-title":"Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges","volume":"17","author":"Mitoma","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.xcrm.2026.102822_bib42","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.xcrm.2026.102822_bib43","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1172\/JCI78084","article-title":"Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity","volume":"125","author":"Suurmond","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102822_bib44","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1177\/10600280231218253","article-title":"Lecanemab: A Humanized Monoclonal Antibody for the Treatment of Early Alzheimer Disease","volume":"58","author":"Park","year":"2024","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.xcrm.2026.102822_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.106053","article-title":"Neural synaptic vesicle autoimmunity following aerosolized porcine neural tissue exposure: insights into autoimmune inflammatory polyradiculoneuropathy","volume":"122","author":"Hinson","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2026.102822_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads4661","article-title":"Synaptophysin accelerates synaptic vesicle fusion by expanding the membrane upon neurotransmitter loading","volume":"11","author":"Preobraschenski","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.102822_bib47","doi-asserted-by":"crossref","first-page":"14032","DOI":"10.1523\/JNEUROSCI.3162-11.2011","article-title":"Synaptophysin is required for synaptobrevin retrieval during synaptic vesicle endocytosis","volume":"31","author":"Gordon","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.xcrm.2026.102822_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/srep13659","article-title":"Architecture of the Synaptophysin\/Synaptobrevin Complex: Structural Evidence for an Entropic Clustering Function at the Synapse","volume":"5","author":"Adams","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102822_bib49","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.40744","article-title":"Elevated synaptic vesicle release probability in synaptophysin\/gyrin family quadruple knockouts","volume":"8","author":"Raja","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2026.102822_bib50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0896-6273(92)90038-F","article-title":"Antibodies to synaptophysin interfere with transmitter secretion at neuromuscular synapses","volume":"9","author":"Alder","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.xcrm.2026.102822_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100266","article-title":"Synaptophysin controls synaptobrevin-II retrieval via a cryptic C-terminal interaction site","volume":"296","author":"Harper","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2026.102822_bib52","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/s41593-018-0192-3","article-title":"Epigenetic regulation of brain region-specific microglia clearance activity","volume":"21","author":"Ayata","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.xcrm.2026.102822_bib53","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nn.4222","article-title":"Microglial brain region-dependent diversity and selective regional sensitivities to aging","volume":"19","author":"Grabert","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.xcrm.2026.102822_bib54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneuroim.2006.06.019","article-title":"Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli","volume":"179","author":"Silwedel","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.xcrm.2026.102822_bib55","article-title":"Corrigendum: Patients' IgLON5 autoantibodies interfere with IgLON5-protein interactions","volume":"14","author":"Landa","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102822_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2025.102579","article-title":"Animal models of autoimmune encephalitis","volume":"95","author":"Maudes","year":"2025","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.xcrm.2026.102822_bib57","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200145","article-title":"Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease","volume":"10","author":"McKeon","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.xcrm.2026.102822_bib58","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.O111.016253","article-title":"Rapid identification of monospecific monoclonal antibodies using a human proteome microarray","volume":"11","author":"Jeong","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.xcrm.2026.102822_bib59","doi-asserted-by":"crossref","first-page":"13695","DOI":"10.1523\/JNEUROSCI.0636-13.2013","article-title":"X-linked intellectual disability-associated mutations in synaptophysin disrupt synaptobrevin II retrieval","volume":"33","author":"Gordon","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.xcrm.2026.102822_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010455","article-title":"Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica","volume":"5","author":"Mader","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.102822_bib61","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.xcrm.2026.102822_bib62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clim.2010.11.013","article-title":"Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases","volume":"138","author":"Di Pauli","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.xcrm.2026.102822_bib63","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/mp.2016.165","article-title":"Caspr2-reactive antibody cloned from a mother of an ASD child mediates an ASD-like phenotype in mice","volume":"21","author":"Brimberg","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.xcrm.2026.102822_bib64","doi-asserted-by":"crossref","first-page":"11368","DOI":"10.1523\/JNEUROSCI.3795-04.2004","article-title":"Different presynaptic roles of synapsins at excitatory and inhibitory synapses","volume":"24","author":"Gitler","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.xcrm.2026.102822_bib65","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1084\/jem.20150951","article-title":"Conditional deletion of L1CAM in human neurons impairs both axonal and dendritic arborization and action potential generation","volume":"213","author":"Patzke","year":"2016","journal-title":"J. Exp. Med."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:09:09Z","timestamp":1783145349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126002399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666379126002399"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102822","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synaptophysin autoantibodies mediate synaptic dysfunction in cerebellar ataxia","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102822"}}